Mankind Pharma Ltd. · Q3FY26
Result on 3 Feb 2026, first traded on 4 Feb 2026; judged on 15 Sep 2026. The last read before it, on 31 Jan 2026 (3 days ahead), called it neutral, rank 133 of 298 reporting; the share then lagged the market over ten sessions. The company's page →
flat / no callverdict
neutralthe read
-4.4%vs market, 10 sessions
-3.8%T+1
1 · What the read said
morning of 31 Jan- Read
- neutral — rank 133 of 298 reporting that week
- Composite
- 52.2 out of 100
- Evidence
- partial · 11 results on record
- Expected move
- ±4.0% on the day — its average absolute move on results
- Habit
- continuation — the day-one move usually carries on over the following sessions
- Close that morning
- ₹2,124.00
Reactivity · 30%
57
Momentum · 20%
47
vs market · 30%
74
vs sector · 20%
18
Each layer is a percentile among that week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 56.6 + 0.20 × 47.3 + 0.30 × 73.7 + 0.20 × 18.3 = 52.2
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹2,162.60the base every move below is measured from
T+1-3.8%a real move — at least 60% of its usual
T+10-4.0%market +0.4% · sector +1.5%
vs market-4.4%vs sector -5.6%
Best close after-3.4%traded as high as +1.7% on 4 Feb
Worst close after-4.7%traded as low as -6.0% on 6 Feb
Run-up, 30 sessions-0.4%into the result
52-week range20% below high5% above low
- Delivery share
- -4.8 points in the fortnight before, against the month before that
- Volume
- 1.13× its prior month, in the fortnight before
- Habit held
- continuation — could not be checked
- Announced
- Wed, timing unknown
- Peers reporting
- 1 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
1 mornings| Morning | Days ahead | Read | Rank | Comp. | L1 | L2 | L3 | L4 | Close | Note |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan judged simulated | 3 | neutral | 133/298 | 52.2 | 57 | 47 | 74 | 18 | ₹2,124.00 |
A read is made each morning the company is due within seven days. The highlighted morning is the last one before the result — the read this post-mortem judges. Excluded mornings show why the name dropped out that day.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-28 | 22 Dec | 2,190.00 | 2,193.10 | 2,169.60 | 2,186.30 | — | +1.10% | +1.73% | +3.28% |
| T-27 | 23 Dec | 2,186.40 | 2,240.00 | 2,186.40 | 2,229.60 | +1.98% | +3.10% | +1.75% | +3.04% |
| T-26 | 24 Dec | 2,239.90 | 2,247.30 | 2,187.10 | 2,193.30 | -1.63% | +1.42% | +1.61% | +2.51% |
| T-25 | 26 Dec | 2,206.00 | 2,211.40 | 2,171.00 | 2,193.00 | -0.01% | +1.41% | +1.22% | +2.18% |
| T-24 | 29 Dec | 2,200.60 | 2,200.60 | 2,173.00 | 2,182.00 | -0.50% | +0.90% | +0.83% | +1.70% |
| T-23 | 30 Dec | 2,165.00 | 2,177.00 | 2,146.20 | 2,152.50 | -1.35% | -0.47% | +0.82% | +1.53% |
| T-22 | 31 Dec | 2,165.00 | 2,206.90 | 2,150.00 | 2,196.50 | +2.04% | +1.57% | +1.56% | +2.36% |
| T-21 | 1 Jan | 2,202.00 | 2,202.00 | 2,156.00 | 2,164.60 | -1.45% | +0.09% | +1.63% | +1.95% |
| T-20 | 2 Jan | 2,174.10 | 2,205.00 | 2,163.00 | 2,202.70 | +1.76% | +1.85% | +2.34% | +2.66% |
| T-19 | 5 Jan | 2,205.00 | 2,222.00 | 2,184.70 | 2,195.00 | -0.35% | +1.50% | +2.03% | +2.45% |
| T-18 | 6 Jan | 2,205.00 | 2,247.30 | 2,185.00 | 2,240.80 | +2.09% | +3.62% | +1.75% | +4.17% |
| T-17 | 7 Jan | 2,241.00 | 2,320.90 | 2,231.30 | 2,311.80 | +3.17% | +6.90% | +1.61% | +4.89% |
| T-16 | 8 Jan | 2,314.00 | 2,314.00 | 2,250.00 | 2,261.20 | -2.19% | +4.56% | +0.58% | +3.43% |
| T-15 | 9 Jan | 2,250.00 | 2,250.70 | 2,186.00 | 2,200.80 | -2.67% | +1.77% | -0.17% | +2.53% |
| T-14 | 12 Jan | 2,201.50 | 2,232.00 | 2,172.20 | 2,224.30 | +1.07% | +2.85% | +0.24% | +2.11% |
| T-13 | 13 Jan | 2,220.00 | 2,235.00 | 2,190.30 | 2,213.90 | -0.47% | +2.37% | +0.02% | +1.63% |
| T-12 | 14 Jan | 2,224.00 | 2,252.20 | 2,207.10 | 2,244.40 | +1.38% | +3.78% | -0.24% | +1.37% |
| T-11 | 16 Jan | 2,255.50 | 2,255.50 | 2,167.90 | 2,175.40 | -3.07% | +0.59% | -0.13% | +0.08% |
| T-10 | 19 Jan | 2,170.00 | 2,170.00 | 2,110.40 | 2,117.20 | -2.68% | -2.10% | -0.55% | -0.29% |
| T-9 | 20 Jan | 2,112.00 | 2,134.90 | 2,087.00 | 2,124.30 | +0.34% | -1.77% | -1.92% | -2.19% |
| T-8 | 21 Jan | 2,124.30 | 2,129.20 | 2,081.90 | 2,099.10 | -1.19% | -2.94% | -2.22% | -2.77% |
| T-7 | 22 Jan | 2,111.00 | 2,151.90 | 2,104.60 | 2,147.00 | +2.28% | -0.72% | -1.70% | -1.23% |
| T-6 | 23 Jan | 2,150.90 | 2,155.00 | 2,098.00 | 2,107.60 | -1.84% | -2.54% | -2.64% | -2.15% |
| T-5 | 27 Jan | 2,131.40 | 2,131.40 | 2,059.40 | 2,094.20 | -0.64% | -3.16% | -2.15% | -1.85% |
| T-4 | 28 Jan | 2,106.60 | 2,122.80 | 2,065.00 | 2,116.90 | +1.08% | -2.11% | -1.50% | -2.07% |
| T-3 | 29 Jan | 2,107.00 | 2,115.20 | 2,091.70 | 2,100.80 | -0.76% | -2.86% | -1.20% | -2.87% |
| T-2 | 30 Jan | 2,082.60 | 2,147.00 | 2,078.80 | 2,124.00 | +1.10% | -1.78% | -1.58% | -2.19% |
| T-1 | 2 Feb | 2,100.00 | 2,120.00 | 2,046.80 | 2,063.80 | -2.83% | -4.57% | -2.48% | -2.93% |
| base | 3 Feb | 2,133.90 | 2,190.20 | 2,112.30 | 2,162.60 | +4.79% | +0.00% | +0.00% | +0.00% |
| T+1 | 4 Feb result | 2,199.00 | 2,199.00 | 2,057.10 | 2,089.30 | -3.39% | -3.39% | +0.19% | -0.34% |
| T+2 | 5 Feb | 2,095.00 | 2,100.00 | 2,073.00 | 2,080.40 | -0.43% | -3.80% | -0.33% | -0.36% |
| T+3 | 6 Feb | 2,085.00 | 2,085.00 | 2,033.00 | 2,060.20 | -0.97% | -4.74% | -0.13% | -1.08% |
| T+4 | 9 Feb | 2,074.50 | 2,089.00 | 2,055.30 | 2,081.90 | +1.05% | -3.73% | +0.54% | +0.41% |
| T+5 | 10 Feb | 2,089.60 | 2,089.60 | 2,065.00 | 2,073.10 | -0.42% | -4.14% | +0.81% | +0.05% |
| T+6 | 11 Feb | 2,074.90 | 2,089.90 | 2,071.00 | 2,087.00 | +0.67% | -3.50% | +0.88% | +1.05% |
| T+7 | 12 Feb | 2,080.00 | 2,083.40 | 2,055.20 | 2,079.00 | -0.38% | -3.87% | +0.31% | +0.84% |
| T+8 | 13 Feb | 2,076.10 | 2,085.30 | 2,050.10 | 2,060.50 | -0.89% | -4.72% | -1.00% | -0.02% |
| T+9 | 16 Feb | 2,055.00 | 2,085.50 | 2,051.70 | 2,083.30 | +1.11% | -3.67% | -0.17% | +0.91% |
| T+10 | 17 Feb | 2,085.00 | 2,088.30 | 2,060.00 | 2,062.90 | -0.98% | -4.61% | -0.01% | +1.33% |
| T+11 | 18 Feb | 2,059.90 | 2,078.30 | 2,048.00 | 2,075.60 | +0.62% | -4.02% | +0.36% | +1.54% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.